A Multi-Center, Double-Blind, Randomized, Parallel-Group Study to Evaluate Cycle Control and Safety of 6 Different Regimens of an Oral Contraceptive Containing Estradiol and Drospirenone in Healthy Female Volunteers Aged Between 18 and 35 Years Over 7 Cycles.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2015
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Bayer
- 06 May 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2007-005258-22).
- 06 May 2012 Planned number of patients changed from 575 to 600 as reported by European Clinical Trials Database record.
- 26 Jun 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.